Blazar
ActiveAI-nativeML for predicting immunotherapy response in cancer patients.
What it does
Blazar applies machine learning to tumor and blood biomarkers to forecast individual response to immunotherapy. Oncologists and trial teams use these insights to enrich trial cohorts, minimize adverse effects, and accelerate drug development.
Its site says now · captured 2026-08-23
Blazar | Preserve confidence in your results as conditions change
Blazar develops software and methods to help biomedical and translational R&D teams preserve interpretability, traceability, and continuity as workflows evolve.
Next to it in Healthcare and bio · cancer immunotherapy response prediction
- DeaLivePlug and Play
Prediction of side effects in cancer treatment and management of symptoms, along with nutritional support.
- ResistanceBioY Combinator W19
We solve drug resistance for cancer
- Kernal BiologicsY Combinator S20
Kernal is creating mRNA 2.0 therapies that work in specific cells
- Guardian BioY Combinator S22
Dendritic cell-based platform for cancer therapy
- 株式会社メディネットPlug and Play
Cancer immuno-cell therapy is an advanced medical practice.
- リバーセル株式会社Plug and Play
Rebirthel is a biotech company, focused on the Development and operationalization of cell-based cancer immunotherapies.
- Regcell Co., Ltd.Plug and Play
Regcell is a university-originated venture company and aims to develop novel immunotherapies for immunological diseases and cancer by targeting regulatory T cells, which are specialized for immune suppression.
- Adventris PharmaceuticalsY Combinator W23
Adventris makes cancer vaccines